**Sustained measles transmission in under-vaccinated U.S. communities continues to drive case counts higher.** As of June 25, 2026, the CDC has confirmed 2,134 measles cases for the year across 38 jurisdictions and 30 outbreaks, with 93% of cases unvaccinated or of unknown status and most linked to ongoing chains from 2025. Recent weekly additions of 30–43 cases reflect persistent local spread, particularly in areas with MMR coverage below herd-immunity thresholds. CDC officials have highlighted elevated importation risk from international travel during summer months, which could accelerate incidence through July. Official surveillance updates, typically released mid-week, and any new state-reported clusters will provide the clearest near-term signals for traders assessing totals by July 31.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourCas de rougeole aux États-Unis d'ici le 31 juillet ?
Cas de rougeole aux États-Unis d'ici le 31 juillet ?
$38,403 Vol.
31 juil. 2026
2300
89%
2 350
14%
2400
2%
$38,403 Vol.
2300
$10,634 Vol.
89%
2 350
$3,660 Vol.
14%
2400
$14,737 Vol.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**Sustained measles transmission in under-vaccinated U.S. communities continues to drive case counts higher.** As of June 25, 2026, the CDC has confirmed 2,134 measles cases for the year across 38 jurisdictions and 30 outbreaks, with 93% of cases unvaccinated or of unknown status and most linked to ongoing chains from 2025. Recent weekly additions of 30–43 cases reflect persistent local spread, particularly in areas with MMR coverage below herd-immunity thresholds. CDC officials have highlighted elevated importation risk from international travel during summer months, which could accelerate incidence through July. Official surveillance updates, typically released mid-week, and any new state-reported clusters will provide the clearest near-term signals for traders assessing totals by July 31.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Marché ouvert : Jul 1, 2026, 1:41 AM ET
Volume
$38,403Date de fin
31 juil. 2026Marché ouvert
Jul 1, 2026, 1:41 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**Sustained measles transmission in under-vaccinated U.S. communities continues to drive case counts higher.** As of June 25, 2026, the CDC has confirmed 2,134 measles cases for the year across 38 jurisdictions and 30 outbreaks, with 93% of cases unvaccinated or of unknown status and most linked to ongoing chains from 2025. Recent weekly additions of 30–43 cases reflect persistent local spread, particularly in areas with MMR coverage below herd-immunity thresholds. CDC officials have highlighted elevated importation risk from international travel during summer months, which could accelerate incidence through July. Official surveillance updates, typically released mid-week, and any new state-reported clusters will provide the clearest near-term signals for traders assessing totals by July 31.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$38,403Date de fin
31 juil. 2026Marché ouvert
Jul 1, 2026, 1:41 AM ETResolver
0x65070BE91...**Sustained measles transmission in under-vaccinated U.S. communities continues to drive case counts higher.** As of June 25, 2026, the CDC has confirmed 2,134 measles cases for the year across 38 jurisdictions and 30 outbreaks, with 93% of cases unvaccinated or of unknown status and most linked to ongoing chains from 2025. Recent weekly additions of 30–43 cases reflect persistent local spread, particularly in areas with MMR coverage below herd-immunity thresholds. CDC officials have highlighted elevated importation risk from international travel during summer months, which could accelerate incidence through July. Official surveillance updates, typically released mid-week, and any new state-reported clusters will provide the clearest near-term signals for traders assessing totals by July 31.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes